RTW INVESTMENTS, LP Q2 2017 Filing
Filed August 14, 2017
Portfolio Value
$474.4B
Holdings
28
Report Date
Q2 2017
Filing Type
13F-HR
All Holdings (28 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALNYAlnylam Pharmaceuticals Inc | 1,040,607 | $83.0B | 17.50% | |
| 2 | PTCTPTC Therapeutics Inc | 3,304,214 | $60.6B | 12.77% | |
| 3 | —Avexis Inc | 587,117 | $48.2B | 10.17% | |
| 4 | BMYBristol-Myers Squibb Co | 774,675 | $43.2B | 9.10% | |
| 5 | —La Jolla Pharmaceutical Co | 1,107,379 | $33.0B | 6.95% | |
| 6 | RGNXRegenxbio Inc | 1,272,770 | $25.1B | 5.30% | |
| 7 | I9DNArbutus Biopharma Corp | 5,209,823 | $18.8B | 3.95% | |
| 8 | BCRXBioCryst Pharmaceuticals Inc | 3,333,958 | $18.5B | 3.91% | |
| 9 | AGENEURAgenus Inc | 4,277,456 | $16.7B | 3.53% | |
| 10 | ATRAGBXAtara Biotherapeutics Inc | 1,172,744 | $16.4B | 3.46% | |
| 11 | —Oxford Immunotec Global PLC | 846,917 | $14.2B | 3.00% | |
| 12 | —Corium International Inc | 1,632,001 | $12.2B | 2.57% | |
| 13 | —bluebird bio Inc | 104,383 | $11.0B | 2.31% | |
| 14 | TCMDTactile Systems Technology Inc | 372,302 | $10.6B | 2.24% | |
| 15 | EP3OraSure Technologies Inc | 588,256 | $10.2B | 2.14% | |
| 16 | 3M4Masimo Corp | 100,900 | $9.2B | 1.94% | |
| 17 | —Viveve Medical Inc | 1,239,443 | $8.9B | 1.88% | |
| 18 | —Achillion Pharmaceuticals Inc | 1,590,454 | $7.3B | 1.54% | |
| 19 | —Dicerna Pharmaceuticals Inc | 2,078,991 | $6.6B | 1.39% | |
| 20 | VRAYQViewray Inc | 764,335 | $4.9B | 1.04% | |
| 21 | OMEROmeros Corp | 237,453 | $4.7B | 1.00% | |
| 22 | —Spring Bank Pharmaceuticals Inc | 250,000 | $3.4B | 0.71% | |
| 23 | UHSUniversal Health Services Inc | 25,800 | $3.1B | 0.66% | |
| 24 | PODDInsulet Corp | 58,000 | $3.0B | 0.63% | |
| 25 | GBTUSDGlobal Blood Therapeutics Inc | 26,377 | $721.0M | 0.15% | |
| 26 | ARGXArgenx Nv | 24,970 | $530.0M | 0.11% | |
| 27 | —Invuity Inc | 23,830 | $173.0M | 0.04% | |
| 28 | —Sensus Heatlhcare Inc | 155,000 | $93.0M | 0.02% |